Camurus shares jump after stronger-than-expected Q2 results and bullish guidance reaffirmation
Camurus AB shares climbed sharply after the company reported second-quarter and first-half 2026 interim results that showed record product sales, a substantial increase in royalty income and steady profitability. Management reiterated its full-year 2026 guidance and flagged regulatory and clinical milestones expected later in the year, prompting in…